MoonLake Immunotherapeuti...

NASDAQ: MLTX · Real-Time Price · USD
38.90
0.39 (1.01%)
At close: May 23, 2025, 3:59 PM
38.93
0.08%
After-hours: May 23, 2025, 04:04 PM EDT

MoonLake Immunotherapeutics Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
License Revenue 299.6M 299.6M 299.6M
License Revenue Growth 0.00% 0.00% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Selling, General, and Administrative Revenue 11.03M 9.22M 7.38M 6.92M 6.81M 6.93M 5.39M 4.48M 5.52M 5.33M 5.75M 6.25M 5.49M 2.22M 5.6M 2.81M 94.11K 100.75K
Selling, General, and Administrative Revenue Growth +19.58% +25.00% +6.66% +1.61% -1.80% +28.55% +20.29% -18.75% +3.55% -7.29% -8.09% +13.93% +146.71% -60.26% +98.87% +2891.07% -6.60% n/a
Research and Development Revenue 36.46M 39.06M 35.74M 23.63M 12.99M 8.09M 7.59M 8.7M 7.42M 11.37M 9.02M 11.4M 10.45M 12.1M 669.53K 29.87M n/a n/a
Research and Development Revenue Growth -6.65% +9.30% +51.20% +81.92% +60.49% +6.72% -12.85% +17.38% -34.78% +25.98% -20.84% +9.04% -13.58% +1707.01% -97.76% n/a n/a n/a